{'52WeekChange': -0.8136704,
 'SandP52WeekChange': None,
 'address1': '301 North Main Street',
 'address2': 'Suite 100',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 1.83,
 'askSize': 3200,
 'averageDailyVolume10Day': 1367612,
 'averageVolume': 1609231,
 'averageVolume10days': 1367612,
 'beta': None,
 'beta3Year': None,
 'bid': 1.83,
 'bidSize': 800,
 'bookValue': 2.833,
 'category': None,
 'circulatingSupply': None,
 'city': 'Ann Arbor',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 1.975,
 'dayLow': 1.8,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': 0.393,
 'enterpriseToRevenue': None,
 'enterpriseValue': -18350550,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 1.993,
 'fiftyTwoWeekHigh': 10.75,
 'fiftyTwoWeekLow': 1.26,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 12540373,
 'forwardEps': -1.36,
 'forwardPE': -1.3529412,
 'fromCurrency': None,
 'fullTimeEmployees': 37,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.113000005,
 'heldPercentInstitutions': 0.65472,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': 1544400000,
 'lastSplitFactor': '1:15',
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/millendo.com',
 'longBusinessSummary': 'Millendo Therapeutics, Inc., a late-stage '
                        'biopharmaceutical company, engages in the development '
                        'of various treatments for orphan endocrine diseases '
                        "in the United States. The company's lead product "
                        'candidates include livoletide, a potential treatment '
                        'for Prader-Willi syndrome; and nevanimibe, a '
                        'potential treatment for patients with classic '
                        'congenital adrenal hyperplasia. Millendo '
                        'Therapeutics, Inc. is headquartered in Ann Arbor, '
                        'Michigan.',
 'longName': 'Millendo Therapeutics, Inc.',
 'market': 'us_market',
 'marketCap': 34959448,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_204765597',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -46200000,
 'nextFiscalYearEnd': 1640908800,
 'open': 1.95,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '734-845-9000',
 'previousClose': 1.99,
 'priceHint': 4,
 'priceToBook': 0.6494882,
 'priceToSalesTrailing12Months': None,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 1.975,
 'regularMarketDayLow': 1.8,
 'regularMarketOpen': 1.95,
 'regularMarketPreviousClose': 1.99,
 'regularMarketPrice': 1.95,
 'regularMarketVolume': 1231494,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 18999700,
 'sharesPercentSharesOut': 0.052699998,
 'sharesShort': 1001924,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 561085,
 'shortName': 'Millendo Therapeutics, Inc.',
 'shortPercentOfFloat': 0.053000003,
 'shortRatio': 0.44,
 'startDate': None,
 'state': 'MI',
 'strikePrice': None,
 'symbol': 'MLND',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -3.084,
 'twoHundredDayAverage': 4.3241367,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': 'eea77640-eda8-34f0-ad90-e89b7581ef50',
 'volume': 1231494,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.millendo.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '48104'}